Loading...

The Cooper Companies, Inc.

COONASDAQ
HealthcareMedical - Instruments & Supplies
$72.33
$1.15(1.62%)

The Cooper Companies, Inc. (COO) Stock Overview

Explore The Cooper Companies, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
8.41%
8.41%
Profit Growth
$2.07
33.34%
EPS Growth
$2.07
32.21%
Operating Margin
19.00%
32.38%
ROE
5.11%
33.34%
Dividend Yield
0.00%
100.00%

Analyst Recommendations

Strong Buy
Buy
Hold
Sell
Strong Sell

Price Targets

Low$105.00
Average$109.00
High$115.00

Company Profile

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

CEO

Mr. Albert G. White III

Employees

16,000

Headquarters

6101 Bollinger Canyon Road, San Ramon, CA

Founded

1983

Frequently Asked Questions